tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

VIGL Stock Latest News

Vigil likely to land Alzheimer’s deal after today’s data, says Mizuho
The FlyVigil likely to land Alzheimer’s deal after today’s data, says Mizuho
7d ago
VIGL
Vigil Neuroscience Announces Positive Phase 1 Trial Results
PremiumCompany Announcements
Vigil Neuroscience Announces Positive Phase 1 Trial Results
7d ago
8K
VIGL
Vigil Neuroscience reports data from Phase 1 trial on VG-3927
PremiumThe Fly
Vigil Neuroscience reports data from Phase 1 trial on VG-3927
7d ago
VIGL
Vigil Neuroscience initiated with an Outperform at William Blair
PremiumThe Fly
Vigil Neuroscience initiated with an Outperform at William Blair
2M ago
VIGL
Vigil Neuroscience initiated with an Outperform at William Blair
PremiumThe Fly
Vigil Neuroscience initiated with an Outperform at William Blair
2M ago
VIGL
Vigil Neuroscience Advances Key Clinical Programs
PremiumCompany AnnouncementsVigil Neuroscience Advances Key Clinical Programs
3M ago
VIGL
Vigil Neuroscience reports Q3 EPS (47c), consensus (54c)
Premium
The Fly
Vigil Neuroscience reports Q3 EPS (47c), consensus (54c)
3M ago
VIGL
Vigil Neuroscience story ‘gaining momentum,’ says Jefferies
Premium
The Fly
Vigil Neuroscience story ‘gaining momentum,’ says Jefferies
5M ago
VIGL
Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data
PremiumCompany Announcements
Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data
5M ago
8K
VIGL
Vigil Neuroscience announces FDA removed partial clinical hold on VG-3927
PremiumThe Fly
Vigil Neuroscience announces FDA removed partial clinical hold on VG-3927
5M ago
VIGL
Vigil Neuroscience price target lowered to $16 from $17 at Guggenheim
PremiumThe Fly
Vigil Neuroscience price target lowered to $16 from $17 at Guggenheim
6M ago
VIGL
Vigil Neuroscience sees cash runway into 2026
PremiumThe Fly
Vigil Neuroscience sees cash runway into 2026
6M ago
VIGL
Vigil Neuroscience reports Q2 EPS (52c), consensus (55c)
PremiumThe FlyVigil Neuroscience reports Q2 EPS (52c), consensus (55c)
6M ago
VIGL
Vigil Neuroscience publishes new data on CSF1R gene variants
Premium
The Fly
Vigil Neuroscience publishes new data on CSF1R gene variants
6M ago
VIGL
Vigil Neuroscience’s Promising Phase 1 Trial and Alzheimer’s Focus
Premium
Company Announcements
Vigil Neuroscience’s Promising Phase 1 Trial and Alzheimer’s Focus
6M ago
8K
VIGL
Vigil Neuroscience announces interim data from ongoing Phase 1 trial on VG-3927
PremiumThe Fly
Vigil Neuroscience announces interim data from ongoing Phase 1 trial on VG-3927
6M ago
VIGL
Vigil Neuroscience price target lowered to $17 from $24 at H.C. Wainwright
PremiumThe Fly
Vigil Neuroscience price target lowered to $17 from $24 at H.C. Wainwright
7M ago
VIGL
Vigil Neuroscience Advances IGNITE Trial, Eyes Accelerated Approval
PremiumCompany Announcements
Vigil Neuroscience Advances IGNITE Trial, Eyes Accelerated Approval
7M ago
8K
VIGL
Vigil Neuroscience updates clinical development strategy for iluzanebart in ALSP
PremiumThe Fly
Vigil Neuroscience updates clinical development strategy for iluzanebart in ALSP
7M ago
VIGL
Vigil Neuroscience price target raised to $23 from $22 at Wedbush
PremiumThe FlyVigil Neuroscience price target raised to $23 from $22 at Wedbush
7M ago
VIGL
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
Premium
The Fly
Sanofi investing $400M in Vigil Neuroscience, says Guggenheim
7M ago
SNY
VIGL
Vigil Neuroscience announces $40M investment from Sanofi
Premium
The Fly
Vigil Neuroscience announces $40M investment from Sanofi
7M ago
SNY
VIGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >